• 

  Data de-identification for personal health information security

  Data de-identification should be the first option to consider when dealing with Personal Health Information (PHI) security.

• 

  Meeting with the FDA

  Meeting with the FDA can put almost everybody in the company in panic mode. Benefits of FDA meetings and what to expect.

• 

  Do’s and Don’ts of Medical Device Labeling

  Medical device labeling includes all information provided with the device. Article identifies jurisdictions and associated “do’s and don’ts”.

• 

  Ready for FDA UDI compliance

  UDI compliance: What does that mean for your products and your company? Link to additional information about UDIs on the FDA website.

• 

  Digital Health: MEMS, wearables, and the future of medical devices

  Microelectromechanical Systems (MEMS) are tiny computer chips with moving parts. Wearables are information accessibility for medical devices.

• 

  Advice from a former Deputy Director FDA/CDRH Office of Compliance and FDA Investigations

  Interview with Larry Spears, Former Deputy Director FDA/CDRH Office of Compliance and FDA Investigations on prep for regulatory submissions.

• 

  StarFish Analysis: Health Canada online publication of Regulatory Decision Summaries (RDS)

  Health Canada has announced online publication of Regulatory Decision Summaries (RDS) and a list of decisions under review.

• 

  11 Things to avoid to achieve RoHS compliance

  RoHS is still a hot topic. Background on RoHS compliance with 11 parts and processes to watch out for during the design stage.

• 

  Digital Health & medical devices – regulatory and technical implications

  Digital Health & medical device regulatory and technical implications: HIPAA, Mobile Medical App (MMA), Medical Device Data System (MDDS), and app stores.

There are no posts to show